Fri, Dec 19, 2014, 3:51 AM EST - U.S. Markets open in 5 hrs 39 mins


% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • denisgodin89 denisgodin89 Mar 25, 2013 1:35 PM Flag

    News Zacks Recommends Trius Therapeutics

    READ all the news on Yahoo headlines
    Zacks Investment Research is reiterating its 'Buy' recommendation on shares of Trius following the solid top-line data from ESTABLISH-2. We see a partnership for the European commercialization of tedizolid as the single biggest catalyst for the shares in 2013. We believe the stock is well-positioned, with over $80 million in cash and investments, to continue its solid run into the presentation of the full data in September 2013 and the U.S. NDA filing in October 2013. Our price target is $12 per share.


    Sentiment: Strong Buy

13.630.0000(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NQ Mobile Inc.
NYSEThu, Dec 18, 2014 4:05 PM EST
Oracle Corporation
NYSEThu, Dec 18, 2014 4:00 PM EST